Boundary Creek Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,500,000
Closed -$97M 6
2025
Q2
$97M Sell
22,500,000
-204,900
-0.9% -$1.01M 21.23% 2
2025
Q1
$137M Buy
22,704,900
+5,092,900
+29% +$25.8M 36.43% 1
2024
Q4
$69.6M Buy
17,612,000
+7,780,000
+79% +$34.8M 4.54% 5
2024
Q3
$57.5M Buy
9,832,000
+7,832,000
+392% +$38.6M 4.47% 4
2024
Q2
$8.62M Buy
2,000,000
+1,000,000
+100% +$4.79M 0.79% 14
2024
Q1
$4.7M Buy
+1,000,000
New +$3.83M 0.28% 22
2023
Q3
Sell
-2,719,000
Closed -$25.2M 50
2023
Q2
$25.2M Sell
2,719,000
-1,795,000
-40% -$15.2M 1.26% 12
2023
Q1
$37.1M Buy
4,514,000
+1,025,000
+29% +$11.3M 1.11% 12
2022
Q4
$38.9M Buy
+3,489,000
New +$40.6M 1.18% 7

Other funds holding MPT

Boundary Creek Advisors's MPT Position: Q2 2023 in Review

Boundary Creek Advisors sold out of Medical Properties Trust (MPT) in Q2 2023, closing a stake of 2,096,390 shares — an estimated $17.7M sold.

Boundary Creek Advisors first reported a position in MPT in Q1 2023 and held it in 1 quarter. The position peaked at $17.2M in Q1 2023. 596 funds tracked by Wall St. Rank hold MPT as of Q2 2023.

  • Boundary Creek Advisors reported no remaining Medical Properties Trust position as of Q2 2023 after selling out during the quarter.
  • Boundary Creek Advisors sold 2,096,390 Medical Properties Trust shares in Q2 2023, an estimated $17.7M.
  • Boundary Creek Advisors first reported a position in Medical Properties Trust in Q1 2023 and held it in 1 quarter.
  • Boundary Creek Advisors's Medical Properties Trust position peaked at $17.2M in Q1 2023.
  • 596 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2023.

Based on Boundary Creek Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.